NHGRI Researchers Ponder When to Return Results to Relatives of Deceased Participants | GenomeWeb

Insights about disease risks gleaned from a person's genome sequence can be relevant not only to that individual, but also to his or her relatives. People participating in studies that yield clinically important information therefore often decide to share their results with family members. But what if the participant dies before he or she receives the results?

A study in the American Journal of Bioethics by members of the National Human Genome Research Institute's ClinSeq study addresses this issue.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.